A Phase 1 Study of ARRY-614 in Patients with Low or Intermediate-1 RiskMyelodysplastic Syndromes
Phase of Trial: Phase I
Latest Information Update: 02 Jan 2015
At a glance
- Drugs Pexmetinib (Primary)
- Indications Myelodysplastic syndromes
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Array BioPharma
- 29 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Dec 2013 Interim results presented at the 55th Annual Meeting and Exposition of the American Society of Hematology.
- 09 Dec 2013 Mature data from this trial are expected in 2014, according to an Array BioPharma media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History